Rockwell Medical (RMTI) Revenue (2010 - 2026)

Rockwell Medical has reported Revenue for 17 years, with the latest figure at $17.3 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 8.34% year-over-year to $17.3 million; the trailing twelve-month figure through Mar 2026 stood at $67.7 million (down 30.75% YoY), and the FY2025 full-year result was $69.3 million, down 31.76% from the prior year.
• Revenue for Q1 2026 stood at $17.3 million, down from $18.3 million in the prior quarter.
• The five-year high for Revenue was $28.3 million in Q3 2024, with the low at $15.9 million in Q3 2025.
• Historically, Revenue has averaged $20.3 million across 5 years, with a median of $18.9 million in 2025.
• Annual changes were most pronounced in 2024 — Revenue soared 42.88% — and 2025, when it plunged 43.75%.
• Rockwell Medical's Revenue stood at $19.3 million in 2022, then climbed by 14.39% to $22.1 million in 2023, then climbed by 11.64% to $24.7 million in 2024, then retreated by 25.62% to $18.3 million in 2025, then decreased by 5.51% to $17.3 million in 2026.
• The last three Revenue figures came in at $17.3 million (Q1 2026), $18.3 million (Q4 2025), and $15.9 million (Q3 2025), per Business Quant data.